Join to View Full Profile
55 Fruit StBoston, MA 02114
Phone+1 617-726-3850
Fax+1 617-724-0239
Dr. Barmettler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Allergy and Immunology, 2015 - 2017
Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2015
University of Massachusetts Medical SchoolClass of 2012
Certifications & Licensure
ME State Medical License 2021 - 2026
MA State Medical License 2015 - 2025
NH State Medical License 2021 - 2025
RI State Medical License 2021 - 2024
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management.Adrienne H Long, Catherine Aftandilian, Sara Barmettler, Sarah Alexander
Pediatric Blood & Cancer. 2025-05-15 - Reply.Natalia M Sutherland, Sara Barmettler
The Journal of Allergy and Clinical Immunology. 2025-05-01 - Common Variable Immunodeficiency Clinical Manifestations Are Shaped by Presence and Type of Heterozygous NFKB1 Variants.Jie Yin, Kevin M Hayes, Mei-Sing Ong, Joseph P Mizgerd, Charlotte Cunningham-Rundles
The Journal of Allergy and Clinical Immunology. in Practice. 2025-03-01
Press Mentions
Association of Immunoglobulin Levels, Infectious Risk, and Mortality with Rituximab and HypogammaglobulinemiaNovember 2nd, 2018
Outpatient Chemo Desensitization Program Safe, Cuts TimeOctober 31st, 2017
Grant Support
- Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell TherapyMASSACHUSETTS GENERAL HOSPITAL2021–2026
- Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell TherapyMASSACHUSETTS GENERAL HOSPITAL2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
